Clinical Trial: Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

Brief Summary: The purpose of this study is to determine whether Thalidomide is effective in the treatment of arteriovenous malformations in the gastrointestinal tract.